Sunil Hari Shankar, O'Donnell Kathryn A
Department of Molecular Biology, UT Southwestern Medical Center, Dallas, TX, USA.
Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA.
Nat Commun. 2024 May 31;15(1):4652. doi: 10.1038/s41467-024-47607-8.
Patient derived tumor xenografts (PDXs) are important models for pre-clinical testing in cancer research and personalized medicine. PDXs often represent patient tumors with high similarity in terms of histology and driver mutations. However, certain limitations exist that warrant a detailed understanding of PDX heterogeneity and evolution. Hynds et al. demonstrate the relevance of primary tumor heterogeneity in PDX model establishment and explore multi-region sampling to determine the extent to which PDXs represent primary tumors.
患者来源的肿瘤异种移植(PDX)是癌症研究和个性化医疗临床前测试的重要模型。PDX在组织学和驱动基因突变方面通常与患者肿瘤高度相似。然而,存在一些局限性,需要详细了解PDX的异质性和进化。Hynds等人证明了原发性肿瘤异质性在PDX模型建立中的相关性,并探索了多区域采样以确定PDX代表原发性肿瘤的程度。